Biotech companies in USA – List of top 25 best biggest, leading, chinese, software, pharma, plant, biotech companies in California, MA, Connecticut, Florida, Washington, New York and New Jersey, in USA with contact details and address for good jobs for freshers
List of top 25 best biotech companies in USA !
Translate Bio, 29 Hartwell Ave, Lexington, MA 02421, United States. Phone: +1 617-945-7361
They are a leading mRNA therapeutics company developing a new class of potentially transformative medicines to treat diseases caused by protein or gene dysfunction. Using their proprietary mRNA therapeutic platform (MRTTM), they create mRNA that encodes functional proteins. Their mRNA is delivered to the target cell where the cell’s own machinery recognizes it and translates it, restoring or augmenting protein function to treat or prevent disease. Their MRTTM platform has been in development for over ten years, initially at Shire and at Translate since 2016. With the scientific founders of the MRTTM platform part of theirleadership team, they have built on Shire’s initial pioneering work and investment to advance our goal of bringing their transformative mRNA approach to patients.
They are primarily focused on applying the MRT platform to pulmonary diseases caused by insufficient protein production or where production of proteins can modify disease. Their lead program is being developed as a treatment for cystic fibrosis (CF) and is in an ongoing Phase 1/2 clinical trial. They also believe their technology is applicable to a broad range of diseases, including diseases that affect the liver, eye and central nervous system.
Bio-Rad Life Science, 6000 James Watson Dr, Hercules, CA 94547, United States. Phone: +1 510-741-1000
Bio-Rad is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for over 65 years, their products advance the discovery process and improve healthcare. Their customers include university and research institutions, hospitals, public health and commercial laboratories, biotechnology, pharmaceutical, as well as applied laboratories that include food safety and environmental quality. Bio-Rad is among the top five life science companies in the world, providing instruments, software, consumables, reagents, and content for the areas of cell biology, gene expression, protein purification, protein quantitation, drug discovery and manufacture, food safety, and science education.
Offering unrivaled precision and absolute quantification of target DNA or RNA molecules, their unique Digital Droplet technology partitions samples into thousands of microfluidic “droplet” test tubes, providing extremely sensitive and accurate digital answers for life science research, clinical diagnostics, as well as environmental monitoring and food safety testing.
XBiotech, 5217 Winnebago Ln, Austin, TX 78744, United States. Phone: +1 512-386-2900
XBiotech has developed world-leading manufacturing technology to reduce time and cost to bring novel product candidates to human therapies. XBiotech has a fully integrated research and manufacturing center and a separate infectious disease research laboratory at its campus headquarters in Austin, Texas. The Company is developing a pipeline of product candidates targeting both inflammatory and infectious diseases and has developed commercial scale manufacturing technology and infrastructure that reduces the cost and time to launch new product candidates. The Company’s discovery and manufacturing technology makes XBiotech uniquely suited to rapidly identify neutralizing antibodies from humans and to quickly manufacture these product candidates for human use.
Fortress Biotech, 2 Gansevoort St, New York, NY 10014, United States. Phone: +1 781-652-4500
At Fortress Biotech, Inc., they leverage their extensive biopharmaceutical business and comprehensive drug development expertise to build a pipeline of both commercial-stage products and development-stage product candidates, as well as to advance their products and pipeline as efficiently as possible with partners. They are dedicated to developing novel therapies and solutions for a wide variety of patients in need. Their pipeline of more than 25 programs developed across partner companies spans several large-market therapeutic areas and includes multiple late-stage product candidates.
Goldfinch Bio, 215 First St, Cambridge, MA 02142, United States. Phone: +1 617-337-4200
Goldfinch brings together experts in the field and experienced leaders with a shared mission to pioneer new treatments for patients with kidney disease. Advances in kidney transplantation and dialysis over half a century ago extended life for patients with kidney failure, yet the current standard of care for patients with kidney disease remains inadequate, and there is an urgent need for new treatment options. Recent breakthroughs in genetics and biology have generated an unparalleled understanding of the biological pathways that drive kidney disease. Goldfinch Bio is uniquely positioned to translate these discoveries into new therapies that target the molecular causes for diseases of the kidney.
Takara Bio USA, Inc., 1290 Terra Bella Ave, Mountain View, CA 94043, United States. Phone: +1 650-919-7300
Takara Bio USA Inc is a member of the Takara Bio Group, a leading life sciences company that is committed to improving the human condition through biotechnology. Through their Takara, Clontech, and Cellartis brands, their mission is to develop high-quality innovative tools and services to accelerate discovery.
CSBio, 20 Kelly Ct, Menlo Park, CA 94025, United States. Phone: +1 650-322-1111
CSBio is a leading peptide and instrumentation manufacturing company located on the edge of Silicon Valley in Menlo Park, California. Since 1993, CSBio has been providing high quality custom peptides, cGMP peptides and automated peptide synthesizers to the global pharmaceutical community. Their peptide products and instrumentation can be found in production laboratories and pharmaceutical companies worldwide. Their state of the art cGMP manufacturing facility and vertically integrated design and manufacturing engineering team provides the best in class products and services in the industry.
RedShiftBio, 131 Middlesex Turnpike, Burlington, MA 01803, United States. Phone: +1 781-345-7300
They developed their Microfluidic Modulation Spectroscopy (MMS) platform in response to a customer’s request for a better solution, and rather than repurpose outdated tools and methods designed originally for other applications, they developed MMS from the ground up specifically with the protein scientist in mind. In 2015, in response to the unique capabilities and potential of MMS, they pivoted their spectroscopy business to focus entirely on bringing innovative analytical solutions to the protein scientist. The RedShiftBio team now includes talented Life Science veterans, protein scientists and instrumentation engineers. They are financially backed by venture capitalists and Waters Corporation, a leading provider of analytical instrumentation for the life sciences with annual sales of over $2 billion. At RedShiftBio, they develop tools to help protein scientists see more clearly.
Amyris, Inc, 5885 Hollis St #100, Emeryville, CA 94608, United States. Phone: +1 510-450-0761
From plant-sugars to anti-malarial drugs, their proprietary process of engineering organisms (yeast) uses renewably-sourced carbon from plants to make sustainable, custom molecules that allow customers to make better, more effective products that are better for people and better for the planet. From developing low-cost nutraceuticals to pioneering a zero-calorie sugar replacement, they are helping create products that are good for people and good for the planet. Also, through their many partnerships and direct to consumer brand Biossance, they are mainstreaming sustainability through cosmetic ingredients and products that are better for consumers and better for the planet. Besides, by providing pure, reliable and sustainable ingredients to the largest fragrance and flavor houses and in the world, they help deliver formulations that are good for people and good for the planet.
CRISPR Therapeutics, 610 Main St, Cambridge, MA 02139, United States. Phone: +1 617-315-4600
They are rapidly translating their specific, efficient and versatile CRISPR/Cas9 gene-editing platform into therapies to treat hemoglobinopathies, cancer, diabetes and other diseases. Their multi-disciplinary team of world-class researchers and drug developers works every day to translate their CRISPR/Cas9 technology into breakthrough human therapeutics. Their lead program targeting the blood diseases β-thalassemia and sickle cell disease has entered clinical testing, as has their first allogeneic CAR-T program targeting B-cell malignancies. They are also advancing additional blood stem cell, immuno-oncology, regenerative medicine and in vivo programs towards the clinic.
Cell Culture Company, 8500 Evergreen Blvd, Minneapolis, MN 55433, United States. Phone: +1 763-786-0302
Cell Culture Company (C3) delivers whole cell pellets, cell lysates, custom monoclonal antibody and recombinant protein manufacturing services from development to commercialization. They employ traditional cell culture methods as well as automated, single-use, perfusion bioreactors. For more than 30 years, they have been focused on providing the right solutions supporting research through commercialization. They serve the diagnostic, genomic, animal health, food safety, pre-clinical and therapeutic industries.
Vigilant Biosciences, 500 W Cypress Creek Rd #300, Fort Lauderdale, FL 33309, United States. Phone: +1 954-487-1740
Vigilant Biosciences® develops advanced and highly accurate methods to aid in the early detection of oral and oropharyngeal cancer through the detection of CD44 and total protein levels collected in a saline solution. This proprietary technology serves as the platform for the first and only tests to aid in the diagnosis of oral and oropharyngeal cancer by detecting a tumor-initiating and stem cell-associated biomarker. Vigilant Biosciences has developed products for the early detection of oral and oropharyngeal cancer for both the U.S. and non-U.S. markets. These tests empower healthcare providers to improve lives through earlier intervention.
Neurocrine Biosciences Inc., 12780 El Camino Real, San Diego, CA 92130, United States. Phone: +1 858-617-7600
Neurocrine Biosciences is a neuroscience-focused, biopharmaceutical company with more than 25 years of experience discovering and developing life-changing treatments for people with serious, challenging and under-addressed neurological, endocrine and psychiatric disorders. The company’s diverse portfolio includes FDA-approved treatments for tardive dyskinesia and endometriosis* and clinical development programs in multiple therapeutic areas including Parkinson’s disease, congenital adrenal hyperplasia and uterine fibroids*. Headquartered in San Diego, Neurocrine Biosciences specializes in targeting and interrupting disease-causing mechanisms involving the interconnected pathways of the nervous and endocrine systems.
Cognate Bioservices, 4600 E Shelby Dr #108, Memphis, TN 38118, United States. Phone: +1 901-541-9800
Cognate BioServices is a leading contract development and manufacturing organization focused on cell and cell-mediated gene therapy products. Cognate has a wide range of operating, technical and leadership experience spanning cell and cell-mediated gene therapy products, with unique expertise in immunotherapy and regenerative medicine and a commitment to commercial readiness and PAI inspection for personalized and off-the-shelf cellular immunotherapy products including but not limited to, CAR-T, TCR, TIL, MIL, DC, and NK cells.
In their operating history they’ve successfully manufactured and delivered products to and from the US, EU and Asia. They’ve handled all aspects of the supply chain, manufacturing, storage, shipping and clinical trial logistics. They partner with clients to provide regulatory support for protocol and IND development for complex products involving multiple drug substance intermediates all the way to minimally manipulated primary cells.
Anika Therapeutics, Inc, 32 Wiggins Ave, Bedford, MA 01730, United States. Phone: +1 781-457-9000
Anika is a biomedical joint preservation company that leverages proprietary regenerative and restoration therapies to help people feel better faster and remain active. For nearly 30 years and 35 million procedures worldwide, Anika has been passionately advancing quality patient care by enabling people to continue doing what they love. Anika offers a broad spectrum of therapeutic treatments ranging from osteoarthritis pain management to joint preservation and restoration. Their proprietary technology is based on hyaluronic acid (HA), a naturally occurring polymer found throughout the body vital for proper joint health and tissue function.
The other companies that complete this list of top 25 best biotech companies in USA includes the following:
Amgen, One Amgen Center Drive, Thousand Oaks, CA- 91320-1799. Phone:+1 805-447-1000. Fax: +1 805-447-1010.
Amgen is committed to unlocking the potential of biology for patients suffering from serious illnesses by discovering, developing, manufacturing and delivering innovative human therapeutics. This approach begins by using tools like advanced human genetics to unravel the complexities of disease and understand the fundamentals of human biology. Amgen focuses on areas of high unmet medical need and leverages its biologics manufacturing expertise to strive for solutions that improve health outcomes and dramatically improve people’s lives.
A biotechnology pioneer since 1980, Amgen has grown to be one of the world’s leading independent biotechnology companies, has reached millions of patients around the world and is developing a pipeline of medicines with breakaway potential. Amgen’s medicines treat serious illnesses. They have a presence in more than 75 countries worldwide and have reached millions of people in the fight against cancer, kidney disease, rheumatoid arthritis, bone disease and other serious illnesses. Their medicines typically address diseases for which the number of effective treatment options is limited, or they are medicines that provide a viable option to what is otherwise available.
Gilead Sciences, 333 Lakeside Drive, Foster City, CA 94404. Phone: (650) 574-3000. Fax: (650) 578-9264.
Gilead Sciences, Inc. is a research-based biopharmaceutical company that discovers, develops and commercializes innovative medicines in areas of unmet medical need. They strive to transform and simplify care for people with life-threatening illnesses around the world. Gilead’s portfolio of products and pipeline of investigational drugs includes treatments for HIV/AIDS, liver diseases, cancer, inflammatory and respiratory diseases, and cardiovascular conditions. Their portfolio of marketed products includes a number of category firsts, including complete treatment regimens for HIV infection available in a once-daily single pill and the first oral antiretroviral pill available to reduce the risk of acquiring HIV infection in certain high-risk adults.
Celgene, Celgene Corporation, 86 Morris Avenue, Summit, NJ 07901. Phone: +1-908-673-9000.
At Celgene, they seek to deliver truly innovative and life-changing drugs for patients. Their vision as a company is to build a major global biopharmaceutical corporation while focusing on the discovery, the development, and the commercialization of products for the treatment of cancer and other severe, immune, inflammatory conditions. There are more than 300 clinical trials at major medical centers using compounds from Celgene.
Investigational compounds are being studied for patients with incurable hematological and solid tumor cancers, including multiple myeloma, myelodysplastic syndromes, chronic lymphocytic leukemia (CLL), non-Hodgkin’s lymphoma (NHL), small cell lung cancer and prostate cancer. As committed as they are to clinical accomplishment, they are equally committed to patient support, which is a guiding principle at Celgene. Celgene puts patients first with industry-leading programs that provide information, support and access to innovative therapies.
Biogen Idec, 225 Binney Street, Cambridge, MA 02142. Phone: 781-464-2000.
Founded in 1978 by a small group of visionary scientists, Biogen helped pioneer the biotechnology industry. Today, they are one of the oldest independent biotechnology companies in the world. For close to four decades, hundreds of thousands of people around the world living with serious illnesses have benefited from innovative and important medicines developed by the people of Biogen. They are building on this legacy of great science and discovery as they pursue increasingly complex challenges.
Regeneron, 777 Old Saw Mill River Road, Tarrytown, NY 10591. 914-847-7000.
They have an extensive pipeline of investigational product candidates that are progressing through all stages of human clinical trials. Their product candidates address many serious medical conditions including cancer, eye diseases, inflammatory diseases, pain, cardiovascular diseases, and allergic conditions. In 2014, Regeneron and Geisinger Health System announced major human genetics research collaboration. Also Regeneron and Avalanche Biotechnologies announced collaboration to develop next-generation gene therapy products in ophthalmology.
Alexion Pharmaceuticals, 352 Knotter Drive, Cheshire, CT 06410. Phone: 203-272-ALXN (2596). Fax: 203-271-8198.
Alexion is a global biopharmaceutical company focused on developing and delivering life-transforming therapies for patients with severe and life-threatening rare diseases. Patients with these devastating diseases often have no effective treatment options, and they and their families suffer with little hope. Their goal is to deliver medical breakthroughs where none currently exist. Alexion is investigating eculizumab as a treatment for patients with additional life-threatening rare disorders in which the inhibition of terminal complement has potentially transformative benefits for patients. These include disorders in the areas of neurology and transplant. Their global headquarters and research operations are in Cheshire, Conn., and will move to New Haven, Conn. in 2015. Alexion’s approximately 2,400 employees serve patients in 50 countries.
Vertex Pharmaceuticals, 50 Northern Avenue, Boston, MA 02210. Tel: 617-341-6100
Vertex is a global biotechnology company that aims to discover, develop and commercialize innovative new medicines so people with serious diseases can lead better lives. Founded in 1989 in Cambridge, MA, Vertex today has research and development sites and commercial offices around the world in the United States, Canada, Europe and Australia. In addition to their clinical development programs focused on cystic fibrosis, Vertex has more than a dozen ongoing research programs aimed at other serious and life-threatening diseases. They collaborate with some of the world’s largest pharmaceutical companies, leading nonprofit disease foundations and many of the world’s best-known academic institutions.
BioMarin Pharmaceuticals, 70 Lindaro Street, San Rafael, CA 94901. Tel: 415-506-6700. Fax: 415-382-7889.
BioMarin develops and commercializes innovative biopharmaceuticals for serious diseases and medical conditions. The company’s product portfolio comprises five approved products and multiple clinical and pre-clinical product candidates. BioMarin has developed and commercialized five products since 1997, a remarkable accomplishment in the biopharmaceutical industry, and a testament to the company’s passion and dedication to patients with serious unmet medical needs.
Actelion Pharmaceuticals US, Inc, 5000 Shoreline Court, Suite 200, 94080 South San Francisco, USA. Tel: 1650 624 6900. Fax: 1650 589 1501.
Actelion Pharmaceuticals Ltd is a biopharmaceutical company headquartered in Allschwil/Basel, Switzerland, that focuses on the discovery, development and commercialization of innovative treatments to serve high unmet medical needs. Located in South San Francisco, their offices are situated in the hub of California’s pharmaceutical and biotech development region. Actelion has subsidaries in over 30 countries, covering all major pharmaceutical markets worldwide.
Seattle Genetics, 21823 – 30th Drive S.E., Bothell, WA 98021. Telephone: 425-527-4000. Fax: 425-527-4001. Email: contact@seagen.com
Seattle Genetics is a biotechnology company focused on developing and commercializing innovative, empowered antibody-based therapies for the treatment of cancer. They are the industry leader in antibody-drug conjugates (ADCs), a technology designed to harness the targeting ability of monoclonal antibodies to deliver cell-killing agents directly to cancer cells. ADCs are intended to spare non-targeted cells and thus reduce many of the toxic effects of traditional chemotherapy, while potentially enhancing antitumor activity.
ALSO REFER
Biotech companies in San Diego
Pharmaceutical companies in New York City
Pharmaceutical companies in Ireland
Pharmaceutical companies in Germany
Pharmaceutical companies in USA
Pharmaceutical companies in Singapore
Pharmaceutical companies in Australia
Pharmaceutical companies in Canada
Pharmaceutical companies in UK